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STING signaling induces interferon-b production by
intratumoral dendritic cells (DCs), driving T cell prim-
ing within the tumor microenvironment. However, the
impact of antigen-specific tolerance on this process is
not well studied. We therefore examined the efficacy of
in situ tumor delivery of a potent STING-activating
CDN ligand (ML-RR-S2 CDA) in both non-tolerant par-
ental FVB/N and the immune tolerant neu-N transgenic
mice bearing established HER-2+ breast tumors. In non-
tolerant FVB/N mice, single agent intratumoral ML-RR-
S2 CDA injection induced complete tumor regression of
both the injected tumor and a contralateral uninjected
tumor, while also protecting mice from a subsequent
tumor challenge. In contrast, intratumoral injection of
ML-RR-S2 CDA alone in neu-N mice modestly delayed
tumor growth. Furthermore, in contrast to our prior
data that low dose cyclophosphamide could increase
vaccine-induced immunity and tumor-free survival in
neu-N transgenic mice, the sequential delivery of low
dose cyclophosphamide with ML-RR-S2 CDA did not
delay tumor outgrowth relative to ML-RR-S2 CDA
alone. We therefore explored biomarkers of both
STING pathway activation and T cell activity within the
TME of FVB/N and neu-N transgenic mice. Intratu-
moral ML-RR-S2 CDA injection resulted in both high
levels of IFNb production in the TME of tumor bearing
FVB/N mice, and the induction of a durable population
of HER-2-specific CD8+ T cells. In contrast, intratu-
moral ML-RR-S2 CDA injection resulted in low levels
of IFNb production in the TME of tolerant neu-N trans-
genic mice, and the induction of few HER-2-specific
CD8+ T cells. Phenotypic analyses of tumor infiltrating
leukocytes within the TME of untreated neu-N mice
revealed increased expression of PD-1 on CD8+ T cells
and PD-L1 on myeloid cells. Moreover, about 25% of
HER-2+ tumor cells derived from the TME also
expressed PD-L1. The addition of PD-L1 blockade to
low dose cyclophosphamide in sequence with intratu-
moral ML-RR-S2 CDA resulted in a greater delay of
tumor growth than intratumoral ML-RR-S2 CDA injec-
tion alone in neu-N transgenic mice, but did not clear
any mouse of tumor. These findings suggest that multi-
ple mechanisms of immune tolerance limit the ability of
STING pathway activation to lead to HER-2 specific-
CD8+ T cell activation and tumor regression in tolerant
neu-N transgenic mice.
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